Moreover, studies have reported on elevated levels of the inhibitory markers NKB1, CD158b, and KIR3DL-1 in patients with T2D when compared to controls [15, 19, 25, 26, 35]. The gene discussed is KIR2DL3; the disease is type 2 diabetes mellitus.